Billiontoone, Inc. (NASDAQ:BLLN) Receives Consensus Recommendation of “Moderate Buy” from Analysts

Billiontoone, Inc. (NASDAQ:BLLN) has received an average recommendation of “Moderate Buy” from the ten analysts that are covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating, three have given a hold rating and six have given a buy rating to the company. The average 1 year price target among analysts that have updated their coverage on the stock in the last year is $126.7143.

Several equities analysts have recently weighed in on BLLN shares. Guggenheim began coverage on Billiontoone in a research report on Monday, June 29th. They issued a “buy” rating and a $125.00 target price on the stock. BTIG Research reduced their price objective on Billiontoone from $142.00 to $130.00 and set a “buy” rating for the company in a research note on Thursday. Weiss Ratings raised shares of Billiontoone from a “sell (d)” rating to a “sell (d+)” rating in a research note on Tuesday, June 23rd. Wall Street Zen lowered shares of Billiontoone from a “buy” rating to a “hold” rating in a report on Saturday. Finally, JPMorgan Chase & Co. reduced their target price on shares of Billiontoone from $145.00 to $130.00 and set an “overweight” rating for the company in a research report on Thursday.

Insider Buying and Selling

In other news, insider Shan Riku Sakakibara sold 8,000 shares of the business’s stock in a transaction that occurred on Wednesday, June 24th. The stock was sold at an average price of $110.00, for a total transaction of $880,000.00. Following the transaction, the insider directly owned 208,000 shares in the company, valued at $22,880,000. The trade was a 3.70% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Nancy Joann Johnson sold 10,582 shares of the stock in a transaction that occurred on Tuesday, June 9th. The shares were sold at an average price of $100.47, for a total value of $1,063,173.54. Following the completion of the sale, the insider directly owned 21,900 shares of the company’s stock, valued at approximately $2,200,293. This represents a 32.58% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders have sold 202,049 shares of company stock valued at $23,496,861. 50.22% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of BLLN. Rossby Financial LCC acquired a new position in shares of Billiontoone during the 4th quarter valued at about $25,000. Wells Fargo & Company MN acquired a new stake in Billiontoone during the fourth quarter worth about $76,000. Smartleaf Asset Management LLC purchased a new position in Billiontoone during the fourth quarter worth about $80,000. Nano Cap New Millennium Growth Fund L P purchased a new position in Billiontoone during the fourth quarter worth about $82,000. Finally, Renaissance Capital LLC acquired a new position in Billiontoone in the 4th quarter valued at about $201,000.

Billiontoone Stock Up 1.9%

BLLN stock opened at $93.39 on Friday. Billiontoone has a 52 week low of $61.96 and a 52 week high of $150.44. The company has a quick ratio of 10.58, a current ratio of 11.69 and a debt-to-equity ratio of 0.17. The firm has a 50-day simple moving average of $116.49 and a 200-day simple moving average of $94.28. The stock has a market capitalization of $4.30 billion and a P/E ratio of 133.41.

Billiontoone (NASDAQ:BLLN) last issued its quarterly earnings results on Wednesday, August 5th. The company reported $0.15 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.15. Billiontoone had a net margin of 8.04% and a return on equity of 9.96%. The firm had revenue of $109.45 million for the quarter. Equities analysts forecast that Billiontoone will post 0.92 earnings per share for the current fiscal year.

About Billiontoone

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.